Cargando…
Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease
BACKGROUND AND OBJECTIVE: Among patients with chronic obstructive pulmonary disease (COPD), diabetes mellitus (DM) is a common comorbidity and is probably associated with increased systemic inflammation and worse prognosis. Metformin, with its pleiotropic anti-inflammatory and antioxidant actions, m...
Autores principales: | Ho, Te-Wei, Huang, Chun-Ta, Tsai, Yi-Ju, Lien, Angela Shin-Yu, Lai, Feipei, Yu, Chong-Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451256/ https://www.ncbi.nlm.nih.gov/pubmed/30953517 http://dx.doi.org/10.1186/s12931-019-1035-9 |
Ejemplares similares
-
Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortality
por: Ho, Te-Wei, et al.
Publicado: (2017) -
Impact of tobacco-related chronic obstructive pulmonary disease on developmental trajectories of comorbidities in the Taiwan population
por: Ho, Te-Wei, et al.
Publicado: (2020) -
Validity of ICD9-CM codes to diagnose chronic obstructive pulmonary disease from National Health Insurance claim data in Taiwan
por: Ho, Te-Wei, et al.
Publicado: (2018) -
In-Hospital and One-Year Mortality and Their Predictors in Patients Hospitalized for First-Ever Chronic Obstructive Pulmonary Disease Exacerbations: A Nationwide Population-Based Study
por: Ho, Te-Wei, et al.
Publicado: (2014) -
Effectiveness of Telemonitoring in Patients with Chronic Obstructive Pulmonary Disease in Taiwan-A Randomized Controlled Trial
por: Ho, Te-Wei, et al.
Publicado: (2016)